Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Triamcinolone Acetonide in Patients With Serous Pigment Detachment Associated With Age-Related Macular Degeneration

NCT04292756 is registered in ClinicalTrials.gov with The Filatov Institute of Eye Diseases and Tissue Therapy as lead sponsor.

NCT NCT04292756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04292756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Triamcinolone Acetonide in Patients With Serous Pigment Detachment Associated With Age-Related Macular Degeneration
Lead sponsor
The Filatov Institute of Eye Diseases and Tissue Therapy
Phase
Not applicable
Overall status
Completed
Start date
March 27, 2018
Completion date
December 31, 2020
Enrollment
63 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration